JMP Securities believes the manufacturer of an atrial fibrillation device could experience a 70% increase in value.

Shares of medical device provider AtriCure are a lucrative investment opportunity, according to JMP Securities. Analyst Daniel Stauder initiated coverage of the stock with an outperform rating and a price target of $60, suggesting that the shares could increase by almost 70%. Stauder stated that AtriCure is the leading player in treating complex forms of…

Read More

CEO of Web Summit steps down following apology for remarks about the Israel-Hamas conflict

Paddy Cosgrave, the CEO and co-founder of Web Summit, a highly anticipated annual tech conference, has resigned from his position following controversy surrounding his comments on the Israel-Hamas war. The controversy led to the cancellation of attendance by major tech giants including Alphabet (parent company of Google), Meta (formerly known as Facebook), and Amazon. In…

Read More